Emblem Second Generation Subcutaneous Defibrillator Approved in U.S., Europe Boston Scientific received approval in the U.S. and Europe for the Second Generation of its*subcutaneous implantable Defibrillator (S-ICD). The*EMBLEM S-ICD System, originally developed by Cameron Health, a company acquired by Boston Scientific, provides protection against sudden cardiac arrest, but without heart leads used with all other implantable defibrillators.
Since the system delivers electric shocks through a lead placed just under the skin next to the sternum, there’s ** need to run wires into the heart and keep them attached to the moving organ. This is a significant advantage during implantation and avoids post-op complications that are associated with leads that have been k**wn to*detach.
The new Emblem S-ICD is 19% thinner and has a battery life 40% longer than the original device. This means that it will be more comfortable to wear and less **ticeable while requiring fewer replacements. Moreover, the system woks with the company’s*LATITUDE NXT Patient Management System, helping cardiologists to keep track of their patients.
03-19-2015, 02:54 AM
Emblem Second Generation Subcutaneous Defibrillator Approved in U.S., Europe
Boston Scientific received approval in the U.S. and Europe for the Second Generation of its*subcutaneous implantable Defibrillator (S-ICD). The*EMBLEM S-ICD System, originally developed by Cameron Health, a company acquired by Boston Scientific, provides protection against sudden cardiac arrest, but without heart leads used with all other implantable defibrillators.
Since the system delivers electric shocks through a lead placed just under the skin next to the sternum, there’s ** need to run wires into the heart and keep them attached to the moving organ. This is a significant advantage during implantation and avoids post-op complications that are associated with leads that have been k**wn to*detach.
العرض العادي
